Atlas Trials

Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary

Clinical trial NCT00066781 · COMPLETED

Trial details

NCT number
NCT00066781
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma of Unknown Primary
Start date
2004-02-01
Primary completion
2008-04-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.